$16.70
0.71%
Nasdaq, Aug 29, 10:00 pm CET
ISIN
IL0011316309
Symbol
MDWD

MediWound Ltd. Stock price

$16.70
-3.10 15.66% 1M
+0.10 0.60% 6M
-1.10 6.18% YTD
-1.53 8.39% 1Y
+2.28 15.81% 3Y
-8.99 34.99% 5Y
-33.49 66.73% 10Y
-104.19 86.19% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
-0.12 0.71%
ISIN
IL0011316309
Symbol
MDWD
Industry

Key metrics

Basic
Market capitalization
$180.5m
Enterprise Value
$156.1m
Net debt
positive
Cash
$32.4m
Shares outstanding
10.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
9.1 | 7.4
EV/Sales
7.9 | 6.4
EV/FCF
negative
P/B
9.0
Financial Health
Equity Ratio
42.4%
Return on Equity
-97.0%
ROCE
-58.3%
ROIC
-404.1%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$19.9m | $24.3m
EBITDA
$-20.6m | $-18.9m
EBIT
$-22.1m | $-26.0m
Net Income
$-28.0m | $-25.2m
Free Cash Flow
$-19.3m
Growth (TTM | estimate)
Revenue
-1.4% | 20.4%
EBITDA
-50.3% | -1.7%
EBIT
-46.2% | -34.2%
Net Income
-39.9% | 16.6%
Free Cash Flow
13.5%
Margin (TTM | estimate)
Gross
18.4%
EBITDA
-103.8% | -77.5%
EBIT
-111.4%
Net
-140.8% | -103.6%
Free Cash Flow
-97.0%
More
EPS
$-2.6
FCF per Share
$-1.8
Short interest
8.6%
Employees
111
Rev per Employee
$180.0k
Show more

Is MediWound Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

MediWound Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a MediWound Ltd. forecast:

11x Buy
92%
1x Hold
8%

Analyst Opinions

12 Analysts have issued a MediWound Ltd. forecast:

Buy
92%
Hold
8%

Financial data from MediWound Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
20 20
1% 1%
100%
- Direct Costs 16 16
7% 7%
82%
3.66 3.66
37% 37%
18%
- Selling and Administrative Expenses 14 14
23% 23%
70%
- Research and Development Expense 12 12
77% 77%
60%
-21 -21
50% 50%
-104%
- Depreciation and Amortization 1.51 1.51
7% 7%
8%
EBIT (Operating Income) EBIT -22 -22
46% 46%
-111%
Net Profit -28 -28
40% 40%
-141%

In millions USD.

Don't miss a Thing! We will send you all news about MediWound Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MediWound Ltd. Stock News

Neutral
GlobeNewsWire
12 days ago
YAVNE, Israel, August 20, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that Ofer Gonen, Chief Executive Officer, will participate in a fireside chat, hosted by Swayampakula Ramakanth, Managing Director, Senior Equity Research Analyst, on Monday, September 8, 2025 at 4:30p.m. ET at the H.C. Wainwright 27th Ann...
Neutral
Seeking Alpha
18 days ago
MediWound Ltd. (NASDAQ:MDWD ) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Barry J.
Neutral
GlobeNewsWire
18 days ago
VALUE Phase III Trial of EscharEx ® in Venous Leg Ulcers Continues to Enroll Patients NexoBrid ® Manufacturing Expansion on Track; Full Operational Capacity Expected by Year-End 2025 Additional Strategic Research Collaborations Established with Essity and Convatec Second Quarter 2025 Revenue of $5.7 Million, Up 43% from Prior Quarter Conference Call Today, August 14, 2025, at 8:30am Eastern Tim...
More MediWound Ltd. News

Company Profile

MediWound Ltd. is a biopharmaceutical company engaging in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in 2001 and is headquartered in Yavne, Israel.

Head office Israel
CEO Ofer Gonen
Employees 111
Founded 2000
Website www.mediwound.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today